Pentamidine dimesylate

Overview

Pentamidine (MP-601205) dimesylate is an antimicrobial agent and interferes with DNA biosynthetics. Pentamidine dimesylate inhibits parasite Leishmania infantum with an IC 50 of 2.5 μM. Pentamidine dimesylate is a potent and selective protein tyrosine phosphatases (PTPases) and phosphatase of regenerating liver (PRL) inhibitor. Pentamidine dimesylate has the potential for Gambian trypanosomiasis , antimony-resistant leishmaniasis , and Pneumocystis carinii pneumonia treatment. Antitumor and antibacterial activities.

Application

Products | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Infection | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Parasite | Products > Signaling Pathways > Fungal | Products > Signaling Pathways > Phosphatase | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-B0537C
• CAS No.: 6823-79-6
• Molecular Formula: C21H32N4O8S2
• Molecular Weight: 532.63
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source